Published in Women's Health Weekly, January 18th, 2007
The study on alendronate was led by researchers at the University of California, San Francisco, and findings are published in the Journal of the American Medical Association. The research also showed that women at very high risk of painful spine fractures might be better-off continuing treatment.
"This has important implications as it has not been known whether treatment of osteoporosis should be continued indefinitely," said lead author Dennis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly